Your browser doesn't support javascript.
loading
Problems with Evidence Assessment in COVID-19 Health Policy Impact Evaluation (PEACHPIE): A systematic strength of methods review
Noah A Haber; Emma Clarke-Deelder; Avi Feller; Emily R Smith; Joshua Salomon; Benjamin MacCormack-Gelles; Elizabeth M Stone; Clara Bolster-Foucault; Jamie R Daw; Laura A Hatfield; Carrie E Fry; Christopher B Boyer; Eli Ben-Michael; Caroline M Joyce; Beth S Linas; Ian Schmid; Eric H Au; Sarah E Wieten; Brooke A Jarrett; Cathrine Axfors; Van Thu Nguyen; Beth Ann Griffin; Alyssa Bilinski; Elizabeth A Stuart.
Affiliation
  • Noah A Haber; Stanford University
  • Emma Clarke-Deelder; Harvard T. H. Chan School of Public Health
  • Avi Feller; UC Berkeley
  • Emily R Smith; Milken Institute School of Public Health, George Washington University
  • Joshua Salomon; Stanford University School of Medicine
  • Benjamin MacCormack-Gelles; Harvard T.H. Chan School of Public Health
  • Elizabeth M Stone; Johns Hopkins Bloomberg School of Public Health
  • Clara Bolster-Foucault; McGill University
  • Jamie R Daw; Columbia University Mailman School of Public Health
  • Laura A Hatfield; Harvard Medical School
  • Carrie E Fry; Vanderbilt University
  • Christopher B Boyer; Harvard T.H. Chan School of Public Health
  • Eli Ben-Michael; UC Berkeley
  • Caroline M Joyce; McGill University
  • Beth S Linas; MITRE Corp
  • Ian Schmid; Johns Hopkins Bloomberg School of Public Health
  • Eric H Au; University of Sydney
  • Sarah E Wieten; Stanford University
  • Brooke A Jarrett; Johns Hopkins Bloomberg School of Public Health
  • Cathrine Axfors; Stanford University
  • Van Thu Nguyen; Stanford University
  • Beth Ann Griffin; Rand Corporation
  • Alyssa Bilinski; Harvard Graduate School of Arts and Sciences
  • Elizabeth A Stuart; Johns Hopkins Bloomberg School of Public Health
Preprint in En | PREPRINT-MEDRXIV | ID: ppmedrxiv-21250243
ABSTRACT
IntroductionAssessing the impact of COVID-19 policy is critical for informing future policies. However, there are concerns about the overall strength of COVID-19 impact evaluation studies given the circumstances for evaluation and concerns about the publication environment. This study systematically reviewed the strength of evidence in the published COVID-19 policy impact evaluation literature. MethodsWe included studies that were primarily designed to estimate the quantitative impact of one or more implemented COVID-19 policies on direct SARS-CoV-2 and COVID-19 outcomes. After searching PubMed for peer-reviewed articles published on November 26, 2020 or earlier and screening, all studies were reviewed by three reviewers first independently and then to consensus. The review tool was based on previously developed and released review guidance for COVID-19 policy impact evaluation, assessing what impact evaluation method was used, graphical display of outcomes data, functional form for the outcomes, timing between policy and impact, concurrent changes to the outcomes, and an overall rating. ResultsAfter 102 articles were identified as potentially meeting inclusion criteria, we identified 36 published articles that evaluated the quantitative impact of COVID-19 policies on direct COVID-19 outcomes. The majority (n=23/36) of studies in our sample examined the impact of stay-at-home requirements. Nine studies were set aside because the study design was considered inappropriate for COVID-19 policy impact evaluation (n=8 pre/post; n=1 cross-section), and 27 articles were given a full consensus assessment. 20/27 met criteria for graphical display of data, 5/27 for functional form, 19/27 for timing between policy implementation and impact, and only 3/27 for concurrent changes to the outcomes. Only 1/27 studies passed all of the above checks, and 4/27 were rated as overall appropriate. Including the 9 studies set aside, reviewers found that only four of the 36 identified published and peer-reviewed health policy impact evaluation studies passed a set of key design checks for identifying the causal impact of policies on COVID-19 outcomes. DiscussionThe reviewed literature directly evaluating the impact of COVID-19 policies largely failed to meet key design criteria for inference of sufficient rigor to be actionable by policy-makers. This was largely driven by the circumstances under which policies were passed making it difficult to attribute changes in COVID-19 outcomes to particular policies. More reliable evidence review is needed to both identify and produce policy-actionable evidence, alongside the recognition that actionable evidence is often unlikely to be feasible.
License
cc_by_nc_nd
Full text: 1 Collection: 09-preprints Database: PREPRINT-MEDRXIV Type of study: Experimental_studies / Rct / Review / Systematic_reviews Language: En Year: 2021 Document type: Preprint
Full text: 1 Collection: 09-preprints Database: PREPRINT-MEDRXIV Type of study: Experimental_studies / Rct / Review / Systematic_reviews Language: En Year: 2021 Document type: Preprint